Respiratory illnesses and infections are spiking nationally, according to date from the Centers for Disease Control and ...

Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

There may be an increase in vaccine hesitancy but it isn't too late for those who would still want them, one doctor says.

Respiratory syncytial virus, or RSV, is a common virus that infects the nose, throat and lungs, according to the U.S. Centers ...

RSVpreF vaccination is effective against RSV-related lower respiratory tract disease among adults aged 60 years or older.